Inherited colorectal cancer syndromes

Clinics in Colon and Rectal Surgery

Volumn 22, Issue 4, 2009, Pages 198-208

  Gryfe, Robert ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Colorectal cancer; familial adenomatous polyposis; hamartomatous polyps; hereditary nonpolyposis colorectal cancer

Indexed keywords

EID: 78049352412     PISSN: 15310043     EISSN: 15309681     Source Type: Journal    
DOI: 10.1055/s-0029-1242459     Document Type: Article

References (84)

1. Burt R, Neklason D W. Genetic testing for inherited colon cancer. Gastroenterology 2005 128 (6) 1696-1716
2. de la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004 4 (10) 769-780
3. Umar A, Boland C R., Terdiman J P. et al. Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability. J Natl Cancer Inst 2004 96 (4) 261-268 (Pubitemid 38256271)
4. Hampel H, Stephens J A., Pukkala E et al. Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology 2005 129 (2) 415-421
5. Rodriguez-Bigas M A., Boland C R., Hamilton S R. et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda Guidelines. J Natl Cancer Inst 1997 89 1758-1762
6. Dunlop M G., Farrington S M., Carothers A D. et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 1997 6 (1) 105-110
7. Hamilton S R., Liu B, Parsons R E. et al. The molecular basis of Turcot's syndrome. N Engl J Med 1995 332 (13) 839-847
8. Ponti G, Ponz de Leon M. Muir-Torre syndrome. Lancet Oncol 2005 6 (12) 980-987
9. Vasen H F., Mecklin J P., Khan P M., Lynch H T. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991 34 (5) 424-425
10. Gryfe R, Kim H, Hsieh E T. et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000 342 (2) 69-77
11. Kim H, Jen J, Vogelstein B, Hamilton S R. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 1994 145 (1) 148-156
12. Aaltonen L A., Peltomki P, Leach F S. et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993 260 (5109) 812-816
13. Kinzler K W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996 87 (2) 159-170
14. Peltomki P, Vasen H. Mutations associated with HNPCC predispositionUpdate of ICG-HNPCC/INSiGHT mutation database. Dis Markers 2004 20 (4-5) 269-276
15. Ionov Y, Peinado M A., Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993 363 (6429) 558-561
16. Thibodeau S N., Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993 260 (5109) 816-819
17. Boland C R., Thibodeau S N., Hamilton S R. et al. A National Cancer Institute Workshop on Microsatellite Instability for Cancer Detection and Familial Predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998 58 5248-5257
18. Ricciardone M D., Ozelik T, Cevher B et al. Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. Cancer Res 1999 59 (2) 290-293
19. Bandipalliam P. Syndrome of early onset colon cancers, hematologic malignancies & features of neurofibromatosis in HNPCC families with homozygous mismatch repair gene mutations. Fam Cancer 2005 4 (4) 323-333
20. Kane M F., Loda M, Gaida G M. et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 1997 57 (5) 808-811
21. Gill S, Lindor N M., Burgart L J. et al. Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation. Clin Cancer Res 2005 11 (18) 6466-6471
22. Hampel H, Frankel W L., Martin E et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 2005 352 (18) 1851-1860
23. American Society of Clinical Oncology. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 2003 21 (12) 2397-2406
24. Nystrm-Lahti M, Kristo P, Nicolaides N C. et al. Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nat Med 1995 1 (11) 1203-1206
25. Gille J J., Hogervorst F B., Pals G et al. Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer 2002 87 (8) 892-897
26. Raevaara T E., Korhonen M K., Lohi H et al. Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1. Gastroenterology 2005 129 (2) 537-549
27. Aaltonen L A., Salovaara R, Kristo P et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998 338 (21) 1481-1487
28. Hampel H, Frankel W L., Martin E et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 2008 26 (35) 5783-5788
29. Barnetson R A., Tenesa A, Farrington S M. et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 2006 354 (26) 2751-2763
30. de Vos tot Nederveen Cappel W H., Nagengast F M., Griffioen G et al. Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families. Dis Colon Rectum 2002 45 (12) 1588-1594
31. Winawer S, Fletcher R, Rex D et al, Gastrointestinal Consortium Panel. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003 124 (2) 544-560
32. Jrvinen H J., Aarnio M, Mustonen H et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000 118 (5) 829-834
33. Burke W, Petersen G, Lynch P et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA 1997 277 (11) 915-919
34. Guillem J G., Wood W C., Moley J F. et al, ASCO SSO. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. J Clin Oncol 2006 24 (28) 4642-4660
35. Church J, Simmang C, Standards Task Force American Society of Colon and Rectal Surgeons Collaborative Group of the Americas on Inherited Colorectal Cancer and the Standards Committee of The American Society of Colon and Rectal Surgeons. Practice parameters for the treatment of patients with dominantly inherited colorectal cancer (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer). Dis Colon Rectum 2003 46 (8) 1001-1012
36. Schmeler K M., Lynch H T., Chen L M. et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 2006 354 (3) 261-269
37. Popat S, Hubner R, Houlston R S. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 2005 23 (3) 609-618
38. Sankila R, Aaltonen L A., Jrvinen H J., Mecklin J P. Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology 1996 110 (3) 682-687
39. Lin K M., Shashidharan M, Ternent C A. et al. Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population. Dis Colon Rectum 1998 41 (4) 428-433
40. Bertario L, Russo A, Sala P et al. Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer. Int J Cancer 1999 80 (2) 183-187
41. Ribic C M., Sargent D J., Moore M J. et al. Tumor microsatellite- instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003 349 (3) 247-257
42. Barratt P L., Seymour M T., Stenning S P. et al, UKCCCR AXIS trial collaborators. Adjuvant X-ray and Fluorouracil Infusion Study. DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study. Lancet 2002 360 (9343) 1381-1391
43. Carethers J M., Smith E J., Behling C A. et al. Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer. Gastroenterology 2004 126 (2) 394-401
44. Jover R, Zapater P, Castells A et al, Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer. Gut 2006 55 (6) 848-855
45. Jover R, Zapater P, Castells A et al, Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status. Eur J Cancer 2009 45 (3) 365-373
46. Halling K C., French A J., McDonnell S K. et al. Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst 1999 91 (15) 1295-1303
47. Kim G P., Colangelo L H., Wieand H S. et al, National Cancer Institute. Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study. J Clin Oncol 2007 25 (7) 767-772
48. Bertagnolli M M., Niedzwiecki D, Compton C C. et al. Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803. J Clin Oncol 2009 27 (11) 1814-1821
49. Lindor N M., Rabe K, Petersen G M. et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 2005 293 (16) 1979-1985
50. Mueller-Koch Y, Vogelsang H, Kopp R et al. Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer. Gut 2005 54 (12) 1733-1740
51. Valle L, Perea J, Carbonell P et al. Clinicopathologic and pedigree differences in Amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status. J Clin Oncol 2007 25 (7) 781-786
52. Ponz de Leon M, Bertario L, Genuardi M et al. Identification and classification of hereditary nonpolyposis colorectal cancer (Lynch syndrome): adapting old concepts to recent advancements. Report from the Italian Association for the Study of Hereditary Colorectal Tumors Consensus Group. Dis Colon Rectum 2007 50 (12) 2126-2134
53. Knudsen A L., Bisgaard M L., Blow S. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer 2003 2 (1) 43-55
54. King J E., Dozois R R., Lindor N M., Ahlquist D A. Care of patients and their families with familial adenomatous polyposis. Mayo Clin Proc 2000 75 (1) 57-67
55. Belchetz L A., Berk T, Bapat B V., Cohen Z, Gallinger S. Changing causes of mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1996 39 (4) 384-387
56. Kinzler K W., Nilbert M C., Su L K. et al. Identification of FAP locus genes from chromosome 5q21. Science 1991 253 (5020) 661-665
57. Nishisho I, Nakamura Y, Miyoshi Y et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991 253 (5020) 665-669 (Pubitemid 21917200)
58. Fearon E R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990 61 (5) 759-767
59. Vogelstein B, Kinzler K W. Cancer genes and the pathways they control. Nat Med 2004 10 (8) 789-799
60. Powell S M., Zilz N, Beazer-Barclay Y et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992 359 (6392) 235-237
61. Laurent-Puig P, Broud C, Soussi T. APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res 1998 26 (1) 269-270
62. Powell S M., Petersen G M., Krush A J. et al. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 1993 329 (27) 1982-1987
63. American Gastroenterological Association. American Gastroenterological Association medical position statement: hereditary colorectal cancer and genetic testing. Gastroenterology 2001 121 (1) 195-197
64. Giardiello F M., Brensinger J D., Petersen G M. et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 1997 336 (12) 823-827
65. Steinbach G, Lynch P M., Phillips R K. et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000 342 (26) 1946-1952
66. Laken S J., Petersen G M., Gruber S B. et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 1997 17 (1) 79-83
67. Gryfe R, Di Nicola N, Gallinger S, Redston M. Somatic instability of the APC I1307K allele in colorectal neoplasia. Cancer Res 1998 58 (18) 4040-4043
68. Gryfe R, Di Nicola N, Lal G, Gallinger S, Redston M. Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism. Am J Hum Genet 1999 64 (2) 378-384
69. Cleary S P., Kim H, Croitoru M E. et al. Missense polymorphisms in the adenomatous polyposis coli gene and colorectal cancer risk. Dis Colon Rectum 2008 51 1467-1473 discussion 1473-1464
70. Joint Test and Technology Transfer Committee Working Group. Genetic Testing for Colon Cancer: Joint Statement of the American College of Medical Genetics and American Society of Human Genetics. Genet Med 2000 2 (6) 362-366
71. Al-Tassan N, Chmiel N H., Maynard J et al. Inherited variants of MYH associated with somatic G:C>T:A mutations in colorectal tumors. Nat Genet 2002 30 (2) 227-232
72. Sieber O M., Lipton L, Crabtree M et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 2003 348 (9) 791-799
73. Croitoru M E., Cleary S P., Di Nicola N et al. Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J Natl Cancer Inst 2004 96 (21) 1631-1634
74. Cleary S P., Cotterchio M, Jenkins M A. et al. Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology 2009 136 (4) 1251-1260
75. Sampson J R., Jones N. MUTYH-associated polyposis. Best Pract Res Clin Gastroenterol 2009 23 (2) 209-218
76. Hemminki A, Markie D, Tomlinson I et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998 391 (6663) 184-187
77. Jenne D E., Reimann H, Nezu J et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 1998 18 (1) 38-43
78. Chow E, Macrae F. A review of juvenile polyposis syndrome. J Gastroenterol Hepatol 2005 20 (11) 1634-1640
79. Howe J R., Roth S, Ringold J C. et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 1998 280 (5366) 1086-1088
80. Howe J R., Bair J L., Sayed M G. et al. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 2001 28 (2) 184-187
81. Gallione C J., Repetto G M., Legius E et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 2004 363 (9412) 852-859
82. Marsh D J., Dahia P L., Zheng Z et al. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 1997 16 (4) 333-334
83. Liaw D, Marsh D J., Li J et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997 16 (1) 64-67
84. Kinzler K W., Vogelstein B. Landscaping the cancer terrain. Science 1998 280 (5366) 1036-1037